Wedbush Maintains Outperform on Passage Bio, Raises Price Target to $40
Benzinga Newsdesk 1 year ago
NewsPrice TargetStock SplitAnalyst Ratings
Wedbush analyst Yun Zhong maintains Passage Bio (NASDAQ:PASG) with a Outperform and raises the price target from $3 to $40.
Wedbush analyst Yun Zhong maintains Passage Bio (NASDAQ:PASG) with a Outperform and raises the price target from $3 to $40.